- Associated Press•yesterday
Drugmaker Merck & Co., focused heavily on its long-term future as it builds sales of crucial new medicines Keytruda for cancer and Zepatier for hepatitis C, still posted a big jump in second-quarter profit ...
|52wk Range||71.00 - 90.60|
|Day's Range||90.60 - 90.60|
|Avg Vol (3m)||1,254|
As of 2:59 PM EDT. Market closed.